EligibleTrials

Clinical trials recruiting for KRAS G12V

Fewer than 3 recruiting trials found.

2
Recruiting trials
19
US states with sites
6
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 1 2Phase 2 1

Drugs and treatments being studied

InterventionTrials
Cetuximab2
Gemcitabine2
Nab-paclitaxel2
BBO-102031
BBO-118181
FOLFIRI1
FOLFOX6/FOLFOX71
Panitumumab1
Pembrolizumab1
Pemetrexed1
Platinum chemotherapy (cisplatin or carboplatin)1
S2416561

Where trials are recruiting (top US states)

StateRecruiting trials
California2
Connecticut2
Massachusetts2
New York2
Tennessee2
Texas2
Washington2
Arizona1
Colorado1
District of Columbia1
Florida1
Illinois1

Top cities

Boston, Massachusetts 2Houston, Texas 2Los Angeles, California 2Nashville, Tennessee 2New Haven, Connecticut 2New York, New York 2San Antonio, Texas 2San Francisco, California 2Seattle, Washington 2Aurora, Colorado 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for KRAS G12V often also study these conditions. Each links to its own recruiting-trial list.

Non-small cell lung cancer 507Lung cancer 2180KRAS G12D 3Colorectal cancer 1359Thyroid Carcinoma 3Thyroid Cancer 21Solid Tumor, Adult 38Solid Carcinoma 6Recurrent Lung Non-Small Cell Carcinoma 12PDAC - Pancreatic Ductal Adenocarcinoma 21

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for KRAS G12V trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.